R&D

NIAB is an autonomous and premier institute of the Department of Biotechnology (DBT), Government of India. The Institute aims to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

Manipal Academy of Higher Education is a globally engaged institution with active partnership with more than 220 leading universities around the globe. Our relations with institutions, government agencies and organisations in study, research and service provide faculty and students access to world-class institutions, experiences and resources.

The Indian Registry of Pathology was established in 1965 under the auspices of the Indian Council of Medical Research in New Delhi, India as a Centre for collection and distribution of teaching material in pathology. The Registry was renamed in 1980 as the National Institute of Pathology (IOP) in view of its expanded scope and activities.

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients in the world.

Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally.

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved.

Urgent Openings in AR&D API Division for GC and GC-MS

The National Innovation Foundation (NIF) India, is India's national initiative to strengthen the grassroots technological innovations and outstanding traditional knowledge. Its mission is to help India become a creative and knowledge-based society by expanding policy and institutional space for grassroots technological innovators.  NIF scouts, supports and spawns' grassroots innovations developed by individuals and local communities in any technological field, helping in human survival without any help from formal sector.

Janssen India, the pharmaceutical division of Johnson & Johnson India, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neuroscience and analgesia, dermatology, infectious diseases and metabolic diseases. Driven by a strong dedication to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world.

National Institute of Malaria Research was established in 1977 as Malaria Research Centre, which was renamed as National Institute of Malaria Research in November 2005. ICMR-NIMR is one of the institutes of the Indian Council of Medical Research an autonomous body under Department of Health Research, Ministry of Health and Family Welfare, Govt. of India.